130 related articles for article (PubMed ID: 30743056)
1. Unaltered prion disease in mice lacking developmental endothelial locus-1.
Zhu C; Li Z; Li B; Pfammatter M; Hornemann S; Aguzzi A
Neurobiol Aging; 2019 Apr; 76():208-213. PubMed ID: 30743056
[TBL] [Abstract][Full Text] [Related]
2. Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling.
Nuvolone M; Paolucci M; Sorce S; Kana V; Moos R; Matozaki T; Aguzzi A
PLoS One; 2017; 12(5):e0177876. PubMed ID: 28545141
[TBL] [Abstract][Full Text] [Related]
3. The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis.
Li B; Chen M; Aguzzi A; Zhu C
J Mol Med (Berl); 2021 Jun; 99(6):877-887. PubMed ID: 33758958
[TBL] [Abstract][Full Text] [Related]
4. Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner.
Kranich J; Krautler NJ; Falsig J; Ballmer B; Li S; Hutter G; Schwarz P; Moos R; Julius C; Miele G; Aguzzi A
J Exp Med; 2010 Sep; 207(10):2271-81. PubMed ID: 20837697
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation, Microglia, and Cell-Association during Prion Disease.
Carroll JA; Chesebro B
Viruses; 2019 Jan; 11(1):. PubMed ID: 30650564
[TBL] [Abstract][Full Text] [Related]
6. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.
Muth C; Schröck K; Madore C; Hartmann K; Fanek Z; Butovsky O; Glatzel M; Krasemann S
Brain Pathol; 2017 Sep; 27(5):590-602. PubMed ID: 27558169
[TBL] [Abstract][Full Text] [Related]
7. Microglia in prion diseases.
Aguzzi A; Zhu C
J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory response of microglia to prions is controlled by sialylation of PrP
Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
[TBL] [Abstract][Full Text] [Related]
9. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation.
Hughes MM; Field RH; Perry VH; Murray CL; Cunningham C
Glia; 2010 Dec; 58(16):2017-30. PubMed ID: 20878768
[TBL] [Abstract][Full Text] [Related]
10. Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein.
Roettger Y; Zerr I; Dodel R; Bach JP
PLoS One; 2013; 8(6):e67743. PubMed ID: 23840767
[TBL] [Abstract][Full Text] [Related]
11. A neuroprotective role for microglia in prion diseases.
Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
[TBL] [Abstract][Full Text] [Related]
12. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.
Bradford BM; McGuire LI; Hume DA; Pridans C; Mabbott NA
Glia; 2022 Nov; 70(11):2169-2187. PubMed ID: 35852018
[TBL] [Abstract][Full Text] [Related]
13. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
[TBL] [Abstract][Full Text] [Related]
14. CD11c is not required by microglia to convey neuroprotection after prion infection.
Carroll JA; Striebel JF; Baune C; Chesebro B; Race B
PLoS One; 2023; 18(11):e0293301. PubMed ID: 37910561
[TBL] [Abstract][Full Text] [Related]
15. Effect of Microglial Inflammation in Prion Disease.
Ano Y; Sakudo A; Onodera T
Curr Issues Mol Biol; 2020; 36():1-12. PubMed ID: 31486773
[TBL] [Abstract][Full Text] [Related]
16. TGFβ1 increases microglia-mediated engulfment of apoptotic cells via upregulation of the milk fat globule-EGF factor 8.
Spittau B; Rilka J; Steinfath E; Zöller T; Krieglstein K
Glia; 2015 Jan; 63(1):142-53. PubMed ID: 25130376
[TBL] [Abstract][Full Text] [Related]
17. Amyloid associated proteins in Alzheimer's and prion disease.
Veerhuis R; Boshuizen RS; Familian A
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):235-48. PubMed ID: 15975027
[TBL] [Abstract][Full Text] [Related]
18. Peripheral prion disease pathogenesis is unaltered in the absence of sialoadhesin (Siglec-1/CD169).
Bradford BM; Crocker PR; Mabbott NA
Immunology; 2014 Sep; 143(1):120-9. PubMed ID: 24684244
[TBL] [Abstract][Full Text] [Related]
19. Complement Regulatory Protein Factor H Is a Soluble Prion Receptor That Potentiates Peripheral Prion Pathogenesis.
Kane SJ; Farley TK; Gordon EO; Estep J; Bender HR; Moreno JA; Bartz J; Telling GC; Pickering MC; Zabel MD
J Immunol; 2017 Dec; 199(11):3821-3827. PubMed ID: 29070671
[TBL] [Abstract][Full Text] [Related]
20. Fibrillar prion peptide (106-126) and scrapie prion protein hamper phagocytosis in microglia.
Ciesielski-Treska J; Grant NJ; Ulrich G; Corrotte M; Bailly Y; Haeberle AM; Chasserot-Golaz S; Bader MF
Glia; 2004 Apr; 46(2):101-15. PubMed ID: 15042579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
